Back to Top Skip to main content Skip to sub-navigation

U.S. Naval Hospital Guam Collects Convalescent Plasma from Sailors

Technician takes notes next to convalescent plasma samples. U.S. Naval Hospital Guam Hospitalman Apprentice Rebekah Morrison records the weight of convalescent plasma units collected from Sailors who recovered from COVID-19. (U.S. Navy Photo by Jaciyn Matanane/Released)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

The COVID-19 Convalescent Plasma Collection Program (CCP) is a Department of Defense effort to collect 10,000 units of convalescent plasma donated by members of the military community who have recovered from the disease. Convalescent plasma will be used to treat critically ill patients and to support the development of an effective treatment against the disease. Eligible donors should contact the Armed Services Blood Program at: https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx to find a complete list of available collection centers.

U.S. Naval Hospital Guam began collecting COVID-19 convalescent plasma (CCP) May 31 in support of the Department of Defense effort to develop therapeutics to support active duty readiness.

USNH Guam coordinated a four-day evolution with Naval Base Guam at the hospital’s Armed Services Blood Bank Center to collect the CCP, which is the liquid part of blood from patients who have recovered from an infection. Recovered COVID-19 patients have virus-specific antibodies that may help those currently fighting COVID-19 recover and keep those who are moderately ill from becoming seriously ill. While there is currently no approved treatment for COVID-19, CCP has been successfully used to counter other viral infections and may help fight this new virus.

During the four-day event, CCP units were collected from 138 volunteers, all Sailors assigned to the aircraft carrier, USS Theodore Roosevelt, who have fully recovered from COVID-19. Their donations will help the larger effort of working towards a possible treatment for COVID-19 and may help others fight the disease.

“We had a 4-day window to recruit and screen volunteer donors, and to collect, manufacture, and test these products,” said Navy Lt. Cmdr. Stephanie Golla, USNH Guam Blood Bank Donor Center department head and Area Joint Blood program officer. “This resulted in the collection of over 200 convalescent plasma units that will be available for transfusion.”

USNH Guam screened all volunteer donors to determine whether they met the eligibility requirements outlined by the U.S. Food and Drug Administration. To be eligible, a donor must be in good health, fully recovered from COVID-19, and meet other specific criteria, such as having a documented positive test.

“We are grateful for their willingness to donate,” said Golla. “This would not have been possible without them.”

Golla expressed that the USS Theodore Roosevelt sailors, with their display of courage and mental fortitude in this endeavor, are exemplary models of our fighting force.

“It feels good to be a part of this process by having a purpose other than being quarantined,” said Navy Aviation Electronics Technician 2nd Class Charles Curry. “I feel grateful for the time USNH Guam staff have taken out of their lives to help us.”

USNH Guam collected CCP to serve in the production of antibody therapeutics and treatment for its service members and beneficiaries infected with the virus. DoD’s efforts to make treatment available at its health care facilities support its mission of a medically ready force.

“This process shows we are step a closer to home and ready to get back to a new normal,” said Curry.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.